Arentje P Manger

No ORCID on file · 4 papers in corpus
rct 2024
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deae071

STUDY QUESTION: What are the costs and effects of tubal patency testing by hysterosalpingo-foam sonography (HyFoSy) compared to hysterosalpingography (HSG) in infertile women during the fertility work-up? SUMMARY ANSWER: During the fertili…

rct 2023
PLoS medicine ·doi:10.1371/journal.pmed.1004323

BACKGROUND: Hysteroscopic resection is the first-choice treatment for symptomatic type 0 and 1 fibroids. Traditionally, this was performed under general anesthesia. Over the last decade, surgical procedures are increasingly being performed …

rct 2022
Human Reproduction ·doi:10.1093/humrep/deac034

STUDY QUESTION: Does hysterosalpingo-foam sonography (HyFoSy) lead to similar pregnancy outcomes, compared with hysterosalpingography (HSG), as first-choice tubal patency test in infertile couples? SUMMARY ANSWER: HyFoSy and HSG produce si…

other 2018
BMC women's health ·doi:10.1186/s12905-018-0556-6

BACKGROUND: Tubal pathology is a causative factor in 20% of subfertile couples. Traditionally, tubal testing during fertility work-up is performed by hysterosalpingography (HSG). Hysterosalpingo-foam sonography (HyFoSy) is a new technique t…